Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
ACE2-spiegel verklaart mogelijk hoger COVID-19-risico bij mannen
mei 2020 | Pneumonie, Virale infecties